TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies.
نویسندگان
چکیده
REFERENCES 1. Fisch MJ, Loehrer PJ, Kristeller J, et al: Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology Group. J Clin Oncol 21:1937-1943, 2003 2. Williams JW Jr, Noel PH, Cordes JA, et al: Is this patient clinically depressed? JAMA 287:1160-1170, 2002 3. Altman DG, Schultz KF, Moher D, et al: The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. Ann Intern Med 134:663-694, 2001 4. Moher D, Schultz KF, Altman DG: The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 285:1987-1991, 2001 5. Stahl SM: Essential psychopharmacology: Neuroscientific basis and practical application. Cambridge, Cambridge University Press, 2000, pp 236-239
منابع مشابه
Association between TGFBR1 Polymorphisms and Cancer Risk: A Meta-Analysis of 35 Case-Control Studies
BACKGROUND Numerous epidemiological studies have evaluated the association between TGFBR1 polymorphisms and the risk of cancer, however, the results remain inconclusive. To derive a more precise estimation of the relation, we conducted a comprehensive meta-analysis of all available case-control studies relating the TGFBR1*6A and IVS7+24G>A polymorphisms of the TGFBR1 gene to the risk of cancer....
متن کاملLack of an association between the TGFBR1*6A variant and colorectal cancer risk.
PURPOSE Recently a common variant of the TGFBR1 gene, TGFBR1*6A, has been proposed to act as a low-penetrance tumor susceptibility allele for colorectal cancer, but data from published studies with individually low statistical power are conflicting. To further evaluate the relationship between TGFBR1*6A and colorectal cancer risk, we have conducted a large case-control study and a meta-analysis...
متن کاملNull Results in Brief Transforming Growth Factor B Receptor Type I and Transforming Growth Factor B1 Polymorphisms Are Not Associated with Postmenopausal Breast Cancer
A polymorphic allele in transforming growth factor h receptor 1 (TGFbR1) is hypothesized to increase risk of cancer (1). The allele, designated as TGFbR1*6A , results from the deletion of three alanines within a nine-alanine stretch in exon 1, and in vitro studies have shown that TGFbR1*6A is an impaired mediator of TGF-h antiproliferative signals compared with wild-type (TGFbR1*9A ; refs. 2, 3...
متن کاملTGFBR1*6A enhances the migration and invasion of MCF-7 breast cancer cells through RhoA activation.
TGFBR1*6A is a common hypomorphic variant of the type 1 transforming growth factor beta receptor (TGFBR1), which has been associated with increased cancer risk in some studies. Although TGFBR1*6A is capable of switching TGF-beta growth-inhibitory signals into growth-stimulatory signals when stably transfected into MCF-7 breast cancer cells, the biological effects of TGFBR1*6A are largely unknow...
متن کاملSomatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development.
TGFBR1*6A is a common hypomorphic variant of the type I transforming growth factor (TGF)-beta receptor (TGFBR1), which transduces TGF-beta growth inhibitory signals less effectively than TGFBR1. Recent studies suggest that TGFBR1*6A confers a selective growth advantage to both normal appearing and cancerous epithelial cells in the presence of TGF-beta. We have previously shown that TGFBR1*6A is...
متن کاملSubtypes of Benign Breast Disease as a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis Protocol
AbstractBreast cancer is a multifactorial disease. Benign breast disease (BBD) is one of the most important risk factors for breast cancer. The etiology of BBD is unknown. It is divided into nonproliferative and proliferative diseases. The selection of studies will be based on titles, abstract screening, inclusion and exclusion criteria, and quality assessment. Previous studies have shown that ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
دوره 22 4 شماره
صفحات -
تاریخ انتشار 2004